Human IL-36 gamma / IL-1F9 Protein, Tag Free (MALS verified)

Cat. No. / Size
Price
Availability
Qty
IL9-H5115-100ug
$310.00
In Stock - Delivery in 1-2 business days
IL9-H5115-1mg
$2,245.00
In Stock - Delivery in 1-2 business days
IL9-H5115
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Synonyms

IL36G, IL-1RP2, IL-1 epsilon, IL-1F9, IL-1H1, IL1E, IL1F9, IL1H1, IL1RP2

Source

Human IL-36 gamma Protein, Tag Free (IL9-H5115) is expressed from E. coli cells. It contains AA Ser 18 - Asp 169 (Accession # Q9NZH8-1).

Predicted N-terminus: Ser 18

Molecular Characterization

This protein carries no "tag".

The protein has a calculated MW of 17.0 kDa. The protein migrates as 15-16 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

Endotoxin

Less than 1.0 EU per μg by the LAL method / rFC method.

Purity

>95% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Shipping and Storage

This product is shipped at ambient temperature.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.

Background

The IL-36 subfamily of cytokines is the most diverse, including three agonists(IL-36α, IL-36β, and IL-36Γ), one antagonist(IL-36Ra), one cognate receptor(IL-36R) and one accessory protein(IL-1RAcP). The receptor activation follows a two-step mechanism in that the agonist first binds to IL-36R and the resulting binary complex recruits IL-1RAcP. IL-36γ that binds to and signals through the IL-36R which in turn activates NF-kappa-B and MAPK signaling pathways in target cells. Appropriately balanced IL-36 signaling is a critical determinant of skin and lung health.